المؤلفون: Hong JH; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore., Yong CH; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Department of Computer Science, National University of Singapore, Singapore., Heng HL; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore.; Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore., Lau MC; Singapore Immunology Network, Agency for Science Technology and Research (A*STAR), Singapore.; Bioinformatics Institute (BII), Agency for Science Technology and Research (A*STAR), Singapore., Chen J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Lee JY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Lim AH; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Li Z; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Guan P; Genome Institute of Singapore, Agency for Science Technology and Research (A*STAR), Singapore., Chu PL; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore., Boot A; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore., Ng SR; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore., Yao X; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore., Wee FYT; Institute of Molecular and Cell Biology, Integrative Biology for Theranostics Lab, Agency for Science Technology and Research (A*STAR), Singapore., Lim JCT; Institute of Molecular and Cell Biology, Integrative Biology for Theranostics Lab, Agency for Science Technology and Research (A*STAR), Singapore., Liu W; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Wang P; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Xiao R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Zeng X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Sun Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Koh J; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore., Kwek XY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Ng CCY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Klanrit P; Cholangiocarcinoma Screening and Care Program (CASCAP), Khon Kaen University, Khon Kaen, Thailand.; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Zhang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong., Lai J; Department of Pancreaticobiliary Surgery, Sun Yat-sen University, Guangzhou, China., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore., Pairojkul C; Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Dima S; Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucuresti, Romania., Popescu I; Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucuresti, Romania., Hsieh SY; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Yu MC; Department of General Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Yeong J; Institute of Molecular and Cell Biology, Integrative Biology for Theranostics Lab, Agency for Science Technology and Research (A*STAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore.; Pathology Academic Clinical Program, Duke-NUS Medical School, Singapore., Kongpetch S; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.; Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Jusakul A; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand., Loilome W; Cholangiocarcinoma Screening and Care Program (CASCAP), Khon Kaen University, Khon Kaen, Thailand.; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand., Tan P; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore.; Genome Institute of Singapore, Agency for Science Technology and Research (A*STAR), Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Tan J; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; State Key Laboratory of Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Teh BT; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore teh.bin.tean@singhealth.com.sg.; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Genome Institute of Singapore, Agency for Science Technology and Research (A*STAR), Singapore.; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore.

المصدر: Gut [Gut] 2024 May 10; Vol. 73 (6), pp. 966-984. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Cholangiocarcinoma*/genetics , Cholangiocarcinoma*/metabolism , Cholangiocarcinoma*/drug therapy , Cholangiocarcinoma*/pathology , Bile Duct Neoplasms*/genetics , Bile Duct Neoplasms*/metabolism , Bile Duct Neoplasms*/pathology , Bile Duct Neoplasms*/drug therapy, Humans ; Animals ; Cell Line, Tumor ; Mice ; Gene Expression Profiling/methods ; Multiomics

المؤلفون: Tham WY; Singapore General Hospital, Department of Nuclear Medicine and Molecular Imaging, Singapore, Singapore., Huang HL; Singapore General Hospital, Department of Nuclear Medicine and Molecular Imaging, Singapore, Singapore., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Allen JC Jr; Duke-NUS Graduate Medical School, Singapore, Singapore., Hwang JSG; Department of Pathology, Singapore General Hospital, Singapore, Singapore., Loh LM; Department of Endocrinology, Singapore General Hospital, Singapore, Singapore., Goh BKP; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore.; Surgery Academic Clinical Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Ong SYK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Singapore, Singapore., Kek PC; Department of Endocrinology, Singapore General Hospital, Singapore, Singapore., Tan DMY; Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore., Ng DCE; Singapore General Hospital, Department of Nuclear Medicine and Molecular Imaging, Singapore, Singapore.; Duke-NUS Graduate Medical School, Singapore, Singapore., Loke KSH; Singapore General Hospital, Department of Nuclear Medicine and Molecular Imaging, Singapore, Singapore.; Duke-NUS Graduate Medical School, Singapore, Singapore.

المصدر: Neuroendocrinology [Neuroendocrinology] 2024; Vol. 114 (9), pp. 840-847. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0035665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0194 (Electronic) Linking ISSN: 00283835 NLM ISO Abbreviation: Neuroendocrinology Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/radiotherapy , Neuroendocrine Tumors*/pathology , Receptors, Peptide*/metabolism, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Treatment Outcome ; Octreotide/analogs & derivatives ; Octreotide/adverse effects ; Octreotide/therapeutic use ; Progression-Free Survival ; Aged, 80 and over ; Asian People ; Radiopharmaceuticals/adverse effects ; Radiopharmaceuticals/administration & dosage ; Radioisotopes/adverse effects ; Radioisotopes/therapeutic use ; Radioisotopes/administration & dosage ; Neoplasm Metastasis

المؤلفون: Tan RSYC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore., Lin Q; Department of Computer Science, National University of Singapore, Singapore., Low GH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Lin R; Department of Computer Science, National University of Singapore, Singapore., Goh TC; Institute of Systems Science, National University of Singapore, Singapore., Chang CCE; Institute of Systems Science, National University of Singapore, Singapore., Lee FF; Institute of Systems Science, National University of Singapore, Singapore., Chan WY; Institute of Systems Science, National University of Singapore, Singapore., Tan WC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore., Tey HJ; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Leong FL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Tan HQ; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore., Nei WL; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore., Chay WY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore., Lai GGY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore., Cheng LT; Duke-NUS Medical School, Singapore.; Department of Diagnostic Radiology, Singapore General Hospital, Singapore., Wong FY; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore., Chua MCH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Chua MLK; Duke-NUS Medical School, Singapore.; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.; Data and Computational Science Core, National Cancer Centre Singapore, Singapore., Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore., Thng CH; Duke-NUS Medical School, Singapore.; Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore., Tan IBH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore.; Data and Computational Science Core, National Cancer Centre Singapore, Singapore., Ng HT; Department of Computer Science, National University of Singapore, Singapore.

المصدر: Journal of the American Medical Informatics Association : JAMIA [J Am Med Inform Assoc] 2023 Sep 25; Vol. 30 (10), pp. 1657-1664.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9430800 Publication Model: Print Cited Medium: Internet ISSN: 1527-974X (Electronic) Linking ISSN: 10675027 NLM ISO Abbreviation: J Am Med Inform Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/diagnostic imaging , Radiology*, Humans ; Machine Learning ; Neural Networks, Computer ; Research Report ; Natural Language Processing

المؤلفون: Lin M; Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore., Bhakdi SC; Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.; X-Zell, Singapore., Tan D; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore., Lee JJX; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore., Pavesi A; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.; Mechanobiology Institute, National University of Singapore, Singapore., Wai LE; Lion TCR Pte Ltd, Singapore., Wang T; Lion TCR Pte Ltd, Singapore., Bertoletti A; Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore., Tan AT; Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.

المصدر: Immunotherapy advances [Immunother Adv] 2023 Aug 14; Vol. 3 (1), pp. ltad015. Date of Electronic Publication: 2023 Aug 14 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE

المؤلفون: Fong KY; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Zhao JJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Sultana R; Centre for Quantitative Medicine, Duke-NUS Graduate Medical School, Singapore, Singapore., Lee JJX; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Lee SY; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Chan SL; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China., Yau T; Department of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China., Tai DWM; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Sundar R; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; The N. 1 Institute for Health, National University of Singapore, Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore, Singapore., Too CW; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore, Singapore.; Division of Radiological Sciences, Singapore General Hospital, Singapore, Singapore.; Radiological Sciences Academic Clinical Program, SingHealth-Duke-NUS Academic Medical Centre, Singapore, Singapore.

المصدر: Liver cancer [Liver Cancer] 2022 Aug 23; Vol. 12 (1), pp. 7-18. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE

المؤلفون: Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Tan TJY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Saw SPL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Lam JYC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Yap YS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Lim WT; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Ng MCH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore. Electronic address: daniel.tan.s.w@singhealth.com.sg.

المصدر: ESMO open [ESMO Open] 2022 Aug; Vol. 7 (4), pp. 100537. Date of Electronic Publication: 2022 Jul 01.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms* , Pandemics*, Humans

المؤلفون: Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Hospital, Singapore gmstanp@duke-nus.edu.sg raghav_sundar@nuhs.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore., Huang KK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Kumar V; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Ramnarayanan K; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Demircioglu D; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., Her Z; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore., Ong X; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Bin Adam Isa ZF; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.; Diagnostic Development Hub (DxD), Agency for Science, Technology and Research, Singapore., Xing M; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.; Diagnostic Development Hub (DxD), Agency for Science, Technology and Research, Singapore., Tan AL; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Tai DWM; Division of Medical Oncology, National Cancer Centre, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre, Singapore.; Curie Oncology, Singapore., Zhai W; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., Lim JQ; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., Das Thakur M; Department of Development Sciences, Genentech, San Francisco, California, USA., Molinero L; Department of Development Sciences, Genentech, San Francisco, California, USA., Cha E; Department of Development Sciences, Genentech, San Francisco, California, USA., Fasso M; Department of Development Sciences, Genentech, San Francisco, California, USA., Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Jeyasekharan AD; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Hospital, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Qamra A; Statistical Programming and Analytics, Roche Canada, Mississauga, Ontario, Canada.; University Health Network, Toronto, Ontario, Canada., Patnala R; Sci-illustrate, Munich, Germany., Fabritius A; Sci-illustrate, Munich, Germany., De Simone M; InSilico Genomics, Phoenix, Arizona, USA., Yeong J; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Ng CCY; Laboratory of Cancer Epigenome, Department of Medical Sciences, National Cancer Centre, Singapore., Rha SY; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea., Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Guo YA; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., Skanderup AJ; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., So JBY; Singapore Gastric Cancer Consortium, Singapore.; Department of Surgery, National University Hospital, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Yong WP; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Hospital, Singapore.; Singapore Gastric Cancer Consortium, Singapore., Chen Q; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Göke J; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., Tan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore gmstanp@duke-nus.edu.sg raghav_sundar@nuhs.edu.sg.; Singapore Gastric Cancer Consortium, Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre, Singapore.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

المصدر: Gut [Gut] 2022 Jul; Vol. 71 (7), pp. 1277-1288. Date of Electronic Publication: 2021 Aug 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Neoplasms*/genetics , Gastrointestinal Neoplasms*/therapy , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/therapy, Animals ; Epigenesis, Genetic ; Epigenomics ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy ; Mice ; Tumor Microenvironment

المؤلفون: Ho J; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Heong V; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore., Peng Yong W; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Soo R; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Ean Chee C; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Wong A; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Sundar R; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Liang Thian Y; Department of Radiology, National University Hospital, Singapore., Gopinathan A; Department of Radiology, National University Hospital, Singapore., Yan Pang M; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Koe P; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Nathan Jeraj S; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Pyar Soe P; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Yar Soe M; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore., Tang T; Department of Haematology-Oncology, National Cancer Centre, Singapore., Ng MCH; Department of Haematology-Oncology, National Cancer Centre, Singapore., Tai DWM; Department of Haematology-Oncology, National Cancer Centre, Singapore., Tan TJY; Department of Haematology-Oncology, National Cancer Centre, Singapore., Xu H; Karyopharm Therapeutics, Newton, MA, USA., Chang H; Karyopharm Therapeutics, Newton, MA, USA., Landesman Y; Karyopharm Therapeutics, Newton, MA, USA., Shah J; Karyopharm Therapeutics, Newton, MA, USA., Shacham S; Karyopharm Therapeutics, Newton, MA, USA., Chin Lee S; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore Cancer Science Institute of Singapore, National University of Singapore, Singapore., Tan DSW; Department of Haematology-Oncology, National Cancer Centre, Singapore., Cher Goh B; Department of Haematology and Oncology, National University Cancer Institute Singapore, Singapore Cancer Science Institute of Singapore, National University of Singapore, Singapore., Tan DSP; Department of Haematology and Oncology, National University Cancer Institute, NUHS Tower Block, Level 7, 1E Kent Ridge Road, Singapore 119228.

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Apr 11; Vol. 14, pp. 17588359221087555. Date of Electronic Publication: 2022 Apr 11 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

المؤلفون: Zhao JJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Tan E; Department of Vascular and Interventional Radiology, Division of Radiological Sciences; Radiological Sciences Academic Clinical Program, SingHealth- Duke-National University of Singapore Academic Medical, Singapore General Hospital, Singapore., Sultana R; Centre for Quantitative Medicine, Duke-National University of Singapore Graduate Medical School, Singapore., Syn NL; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Da Zhuang K; Department of Vascular and Interventional Radiology, Division of Radiological Sciences; Radiological Sciences Academic Clinical Program, SingHealth- Duke-National University of Singapore Academic Medical, Singapore General Hospital, Singapore., Leong S; Department of Vascular and Interventional Radiology, Division of Radiological Sciences; Radiological Sciences Academic Clinical Program, SingHealth- Duke-National University of Singapore Academic Medical, Singapore General Hospital, Singapore., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Too CW; Department of Vascular and Interventional Radiology, Division of Radiological Sciences; Radiological Sciences Academic Clinical Program, SingHealth- Duke-National University of Singapore Academic Medical, Singapore General Hospital, Singapore. Electronic address: too.chow.wei@singhealth.com.sg.

المصدر: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2021 Nov; Vol. 32 (11), pp. 1536-1545.e38. Date of Electronic Publication: 2021 Jun 22.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Society of Cardiovascular and Interventional Radiology Country of Publication: United States NLM ID: 9203369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-7732 (Electronic) Linking ISSN: 10510443 NLM ISO Abbreviation: J Vasc Interv Radiol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy* , Carcinoma, Hepatocellular*/therapy , Chemoembolization, Therapeutic*/adverse effects , Colorectal Neoplasms*/therapy , Embolization, Therapeutic*/adverse effects , Liver Neoplasms*/therapy, Humans ; Survival Rate ; Treatment Outcome

المؤلفون: Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore., Le TBU; Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore., Prawira A; Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore., Ho RZW; Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore., Huynh H; Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore. cmrhth@nccs.com.sg.

المصدر: Hepatology international [Hepatol Int] 2021 Oct; Vol. 15 (5), pp. 1236-1246. Date of Electronic Publication: 2021 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/drug therapy, Animals ; Cell Line, Tumor ; Fibroblast Growth Factors ; Humans ; Mice ; Mice, SCID ; Phenylurea Compounds ; Signal Transduction